Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients.

IF 2 4区医学 Q3 ONCOLOGY

Chemotherapy Pub Date : 2022-01-01 Epub Date: 2021-12-07 DOI:10.1159/000520483

Zeynep Gülsüm Güç, Ahmet Alacacıoğlu, Merve Güleç Yazır, Mehmet Eren Kalender, Sinan Ünal, Utku Oflazoğlu, Yaşar Yıldız, Tarık Salman, Yüksel Küçükzeybek, Hülya Ellidokuz, Mustafa Oktay Tarhan

{"title":"Being a Cancer Patient during the Time of COVID-19: Impact of the Pandemic on the Anxiety and the Sleeping Quality of Oncology Patients.","authors":"Zeynep Gülsüm Güç, Ahmet Alacacıoğlu, Merve Güleç Yazır, Mehmet Eren Kalender, Sinan Ünal, Utku Oflazoğlu, Yaşar Yıldız, Tarık Salman, Yüksel Küçükzeybek, Hülya Ellidokuz, Mustafa Oktay Tarhan","doi":"10.1159/000520483","DOIUrl":null,"url":null,"abstract":"Objective: In this study, we aimed to assess anxiety and sleep quality in cancer patients treated or followed up at our clinic at the time of the outbreak of the COVID-19 pandemic.Methods: Seven hundred and sixty-one patients who were either treated or followed up at our oncology clinic between April 2020 and May 2020 were included. Patients were assessed with the State-Trait Anxiety Inventory (STAI) and the Pittsburgh Sleep Quality Index (PSQI).Results: Mean scores of the 761 participants were STAI, 43.45 ± 9.34 (range, 23-75), and PSQI, 5.67 ± 4.24 (range, 0-19). Quality of sleep was found bad in 447 (58.7%) (global score ≥5). Univariate analyses demonstrated statistical differences by stage of cancer, status of treatment, subgroup of treatment, monthly income, and levels of education in anxiety and sleep quality levels. Multivariate analyses showed active treatment (OR: 21.4; 95% CI: 9.08-50.4; p < 0.001) as the major independent variable that affected sleep quality; the major independent variable associated with anxiety was low income (OR: 4.43; 95% CI: 1.69-11.5; p = 0.002).Conclusion: Anxiety and sleep quality levels were found comparable to pre-pandemic reports, and the pandemic was not observed to have additional negative impact on cancer patients. Also, universal basal anxiety and sleep disorder that accompany cancer or active treatment were observed in our study. The accurate effects of the pandemic can be analyzed in further studies using repeated data obtained from the same patient group.","PeriodicalId":10047,"journal":{"name":"Chemotherapy","volume":null,"pages":null},"PeriodicalIF":2.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805050/pdf/che-0001.pdf","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chemotherapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000520483","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/12/7 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 4

Abstract

Objective: In this study, we aimed to assess anxiety and sleep quality in cancer patients treated or followed up at our clinic at the time of the outbreak of the COVID-19 pandemic.

Methods: Seven hundred and sixty-one patients who were either treated or followed up at our oncology clinic between April 2020 and May 2020 were included. Patients were assessed with the State-Trait Anxiety Inventory (STAI) and the Pittsburgh Sleep Quality Index (PSQI).

Results: Mean scores of the 761 participants were STAI, 43.45 ± 9.34 (range, 23-75), and PSQI, 5.67 ± 4.24 (range, 0-19). Quality of sleep was found bad in 447 (58.7%) (global score ≥5). Univariate analyses demonstrated statistical differences by stage of cancer, status of treatment, subgroup of treatment, monthly income, and levels of education in anxiety and sleep quality levels. Multivariate analyses showed active treatment (OR: 21.4; 95% CI: 9.08-50.4; p < 0.001) as the major independent variable that affected sleep quality; the major independent variable associated with anxiety was low income (OR: 4.43; 95% CI: 1.69-11.5; p = 0.002).

Conclusion: Anxiety and sleep quality levels were found comparable to pre-pandemic reports, and the pandemic was not observed to have additional negative impact on cancer patients. Also, universal basal anxiety and sleep disorder that accompany cancer or active treatment were observed in our study. The accurate effects of the pandemic can be analyzed in further studies using repeated data obtained from the same patient group.

查看原文本刊更多论文

新冠肺炎时期的癌症患者:疫情对肿瘤患者焦虑和睡眠质量的影响

目的:在本研究中，我们旨在评估2019冠状病毒病大流行爆发时在我们诊所治疗或随访的癌症患者的焦虑和睡眠质量。方法:纳入2020年4月至2020年5月在我院肿瘤门诊接受治疗或随访的761例患者。采用状态-特质焦虑量表(STAI)和匹兹堡睡眠质量指数(PSQI)对患者进行评估。结果:761名参与者的平均得分为STAI 43.45±9.34(范围23-75)，PSQI 5.67±4.24(范围0-19)。447人(58.7%)的睡眠质量较差(总体评分≥5)。单变量分析显示了癌症分期、治疗状况、治疗亚组、月收入、受教育程度与焦虑和睡眠质量水平之间的统计学差异。多因素分析显示积极治疗(OR: 21.4;95% ci: 9.08-50.4;P < 0.001)为影响睡眠质量的主要自变量;与焦虑相关的主要自变量是低收入(OR: 4.43;95% ci: 1.69-11.5;P = 0.002)。结论:发现焦虑和睡眠质量水平与大流行前的报告相当，并且没有观察到大流行对癌症患者产生额外的负面影响。此外，普遍的基础焦虑和睡眠障碍伴随癌症或积极治疗在我们的研究中被观察到。可以利用从同一患者群体获得的重复数据，在进一步的研究中分析大流行的准确影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Chemotherapy 医学-药学

CiteScore

5.80

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： This journal publishes original research articles and state-of-the-art reviews on all aspects of antimicrobial and antitumor chemotherapy. The results of experimental and clinical investigations into the microbiological and pharmacologic properties of antibacterial, antiviral and antitumor compounds are major topics of publication. Papers selected for the journal offer data concerning the efficacy, toxicology, and interactions of new drugs in single or combined applications. Studies designed to determine the pharmacokinetic and pharmacodynamics properties of similar preparations and comparing their efficacy are also included. Special emphasis is given to the development of drug-resistance, an increasing problem worldwide.